Clinical Trials Browser

Interventional × Uterine Cervical Dysplasia × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all

NCT05266898 2025-04-18

AGO-Gard

Phase 4 Recruiting

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT05496231 2025-02-03

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

Phase 1/2 Completed

1,080 enrolled 28 charts

Uterine Cervical Dysplasia, Infections